BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Azari F, Kennedy G, Bernstein E, Hadjipanayis C, Vahrmeijer A, Smith B, Rosenthal E, Sumer B, Tian J, Henderson E, Lee A, Nguyen Q, Gibbs S, Pogue B, Orringer D, Charalampaki C, Martin L, Tanyi J, Lee M, Lee JY, Singhal S. Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings. J Biomed Opt 2021;26. [PMID: 34002555 DOI: 10.1117/1.JBO.26.5.050901] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Belashov AV, Zhikhoreva AA, Kruglov SS, Panchenko AV, Semenova IV, Vasyutinskii OS. Analysis of In Vivo Radachlorin Accumulation through FLIM-Assisted Examination of Ex Vivo Histological Samples. Photonics 2022;9:711. [DOI: 10.3390/photonics9100711] [Reference Citation Analysis]
2 Kennedy GT, Azari FS, Bernstein E, Nadeem B, Chang A, Segil A, Sullivan N, Encarnado E, Desphande C, Kucharczuk JC, Leonard K, Low PS, Chen S, Criton A, Singhal S. Targeted detection of cancer cells during biopsy allows real-time diagnosis of pulmonary nodules. Eur J Nucl Med Mol Imaging 2022. [PMID: 35788703 DOI: 10.1007/s00259-022-05868-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Martin LW. Invited Commentary: Intraoperative Molecular Imaging Not Only Facilitates Detection of Pulmonary Metastases but Also Improves Survival. Journal of the American College of Surgeons 2022;234:759-759. [DOI: 10.1097/xcs.0000000000000139] [Reference Citation Analysis]
4 Nath P, Ray A. Highly fluorescent nanoparticles with perovskite core for tumor imaging. Colloidal Nanoparticles for Biomedical Applications XVII 2022. [DOI: 10.1117/12.2609046] [Reference Citation Analysis]
5 Lew B, George M, Blair S, Zhu Z, Liang Z, Ludwig J, Kim CY, Kim K(, Gruev V, Choi H. Protease-activated indocyanine green nanoprobes for intraoperative NIR fluorescence imaging of primary tumors. Nanoscale Adv . [DOI: 10.1039/d2na00276k] [Reference Citation Analysis]
6 Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun 2021;23:100830. [PMID: 34401600 DOI: 10.1016/j.conctc.2021.100830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]